Change Website:
Lab21 Home
Lab21 Clinical Laboratory
Lab21 Diagnostic Products
Lab21 Investor Relations
Search:
Site
Web
Home
Services
News & Events
About Us
Contact Us
Email Alerts
You are here:
Clinical Lab
>
Services
>
Pharma & CROs
>
Pharmacogenetics
Pharmacogenetics
Pharmacogenetics Services
Lab21 pharmacogenetics services for clinical trials include:
DMET panel
Validated genotyping assays
Custom sequencing and genotyping
Nucleic acid extraction
Lab21 can use clinically validated assays, develop custom methods to your specifications, transfer your existing methods to our dedicated pharmacogenetics laboratory and/or develop your current methodology.
Current clinically validated genotyping assays
KRAS Mutation Test
BRAF Mutation Test
EGFR Mutation Test
HLA-B*5701
UGT1A1*28
CYP2B6*4
, 2C9, 2C19, 2D6
Other currently available genotyping assays
Proprietary CES-1 assays
p53
HSP70
DRB070101
DRB4*0103102 NUL
DQB1*0303
DQB1*0101
Lab21 will also develop novel or custom assays as requested.
Contact Us
Click here to Email
T
+44 (0)1223 395450
Hot Topic
Oncology Companion Diagnostics >
Pharma & CRO Services
Service Overview
Companion Diagnostics
Overview
Assay Development
Clinical Trials
Regulatory Approval
Commercialisation
Market Entry
Clinical Trials
Overview
Molecular Diagnostics
Pharmacogenetics
Pharmacology
Viral Drug Resistance
Immunodiagnostics
Preclinical Lead Identification
Therapy Areas
All Therapy Areas
Oncology Experience
HIV Experience
Viral Hepatitis Experience
Lab21
as Your Partner
Partnering with Lab21
Project Management
Data Management & Sample Logistics
Custom Projects and Consultancy